As industries evolve, so does the demand for diverse leadership. From technology to sustainability, these nine career paths ...

Danish privately-held drugmaker MC2 Therapeutics today announced the appointment of Trine Ahlgreen as chief executive (CEO).

Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of ...

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company ...

An associate lawyer with Oyen Wiggs Green & Mutala LLP, Leslie advises Canadian manufacturers to be proactive rather than ...

THE Alicante region is enjoying an unprecedented employment renaissance, with record-breaking job creation suggesting a solid ...

The Philippine Economic Zone Authority (PEZA) has officially approved the country’s largest economic zone (ecozone) to date, ...

For Indian professionals aiming for U.S. permanent residence, the EB-1A green card offers a unique and strategic pathway to explore for securing permanent residency. Unlike many other employment-based ...

This transition reflects a planned and strategic evolution of MC2 Therapeutics, aligned with the company’s focus on commercial expansion.

The rise of regenerative skin treatmentsImagine if you could flip a switch inside your skin cells to make them act younger – ...

May 12, 2025Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.02. Operator: Good day, and welcome to the First Quarter 2025 Harvard Bioscience Inc ...

The United States has long been regarded as a leader in science and technology, yet its innovation pipeline faces growing strain. A convergence of structural inefficiencies, workforce shortages, and ...